Home › annual
 

Keywords :   


Tag: annual

New Data Presented at ASH Annual Meeting Enhance Clinical Knowledge...

2014-12-09 06:57:07| Biotech - Topix.net

Alexion Pharmaceuticals, Inc. today announced that researchers presented data that continue to advance the understanding of atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria and provide further insight into optimal care for patients with these devastating diseases.

Tags: data presented knowledge meeting

 

Monocle launches new annual title The Forecast

2014-12-09 04:51:20| Paper - Topix.net

It is designed to be read over three months, and advertising will be restricted to category-exclusive sponsors Rolex, Audi, Cathay Pacific, UBS, Hapag Lloyd, and Stora Enso. Made up of assessments, photo essays, illustrated portfolios and long reports, the 240 page publication will include copy from a range of correspondents, business minds, historians, urbanists and diplomats "offering views from balance-shifting defence systems to fresh benchmarks in city planning".

Tags: title annual forecast launches

 
 

ModernGraham Annual Valuation Of Stanley Black & Decker, Inc.

2014-12-08 18:28:55| Appliances - Topix.net

The market is implying 6.66% earnings growth over the next 7-10 years, which is within a margin of safety relative to the rate the company has seen in recent years. Stanley Black & Decker has demonstrated stable earnings and solid dividend growth over the last ten years, two traits that will often attract investors.

Tags: inc black annual stanley

 

Data Investigating KEYTRUDA (pembrolizumab), Mercks Anti-PD-1 Therapy, in Patients with Classical Hodgkin Lymphoma Presented at ASH Annual Meeting

2014-12-06 19:00:00| Merck.com - Corporate News

Dateline City: SAN FRANCISCO Overall Response Rate of 66 Percent Observed in KEYTRUDA-treated Patients Whose Cancer Progressed on Brentuximab Vedotin Phase 2 Study Planned for the First Half of 2015 (KEYNOTE-087) SAN FRANCISCO--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today early study findings demonstrating that KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, achieved an overall response rate of 66 percent, as assessed by International Harmonization Project response criteria (n=19/29: 95% CI, 46-82), in transplant-ineligible and failure patients with relapsed/refractory classical Hodgkin Lymphoma (cHL) whose disease progressed on or after treatment with brentuximab vedotin. Language: English Contact: Media:Pamela Eisele, 267-305-3558orClaire Mulhearn, 908-236-1118orInvestor:Joseph Romanelli, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: data presented meeting annual

 

Developing world may need annual $500 bn for climate by 2050

2014-12-06 15:00:00| Climate Ark Climate Change & Global Warming Newsfeed

Agence France-Presse: Developing countries may need as much as $250-500 billion (203-406 billion euros) per year by mid-century to deal with the fallout from climate change, a UN report warned Friday. The projected amount was as much as five times higher than previous estimates and significantly more than today's spending on climate adaptation, said the United Nations Environmental Programme (UNEP), which warned of a "significant funding gap after 2020". "The impacts of climate change are already beginning to be...

Tags: world annual developing climate

 

Sites : [348] [349] [350] [351] [352] [353] [354] [355] [356] [357] [358] [359] [360] [361] [362] [363] [364] [365] [366] [367] next »